BlossomHill Therapeutics
PublicBlossomHill Therapeutics is now publicly traded
The data on this page reflects BlossomHill Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series B
Extension
Dec 10, 2025
Total Funding Raised
$343.65M
Company Overview
BlossomHill Therapeutics is a biopharmaceutical company that discovers and develops small molecule medicines for the treatment of high-need cancers and autoimmune diseases.
Sector
Healthcare
Verticals
Life Sciences, Oncology
AI Layer
Non-AI
Keywords
BlossomHill Therapeutics Comparables
Compare BlossomHill Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| J INTS BIO | 86% | |
| Theseus Pharmaceuticals | 82% | |
| Kestrel Therapeutics | 79% |
BlossomHill Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 10, 2025 | ||||
| Series B | Feb 29, 2024 | ||||
| Series B | Dec 28, 2023 | ||||
| Series A | Mar 3, 2021 |
Key People
Founding team and executive leadership
BlossomHill Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B Extension |
| Janus Henderson Group | Series B Extension |
| H&D Asset Management | Series B |
| Cormorant Asset Management | Series B, Series B Extension, Series A |
| OrbiMed | Series B, Series B Extension, Series A |
| Brahma Capital | Series B Extension |
| Plaisance Capital Management | Series B |
Recent news
Latest coverage and updates
- receives_financingAug 7, 2026
BlossomHill Therapeutics, Inc. received financing of $150M in IPO on Jul 1st '26.
- receives_financingAug 3, 2026
BlossomHill Therapeutics, Inc. was planning to receive financing of $112M in IPO on Aug 3rd '26.
- identified_as_competitor_ofAug 3, 2026
BlossomHill Therapeutics, Inc. was planning to identify as competitor of AstraZeneca group on Aug 3rd '26.
- goes_publicAug 3, 2026
BlossomHill Therapeutics, Inc. went public on Aug 3rd '26.
- goes_publicJul 20, 2026
bhtherapeutics.com is planning to go public.
BlossomHill Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access